The cumulative incidence of chronic GVHD and relapse as a function of H-Y antibody response. Cumulative incidence of chronic GVHD (cGVHD) and disease relapse were determined as competing risks for H-Y antibody-positive and -negative patients. Those patients who did not experience chronic GVHD or relapse were censored at the time of last follow-up or death.